Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Pharmacyclics Company Profile (NASDAQ:PCYC)

Consensus Ratings for Pharmacyclics (NASDAQ:PCYC) (?)
Ratings Breakdown: 6 Hold Rating(s), 8 Buy Rating(s)
Consensus Rating:Buy (Score: 2.57)
Consensus Price Target: $147.13 (52.30% upside)

Current Analysts' Coverage Summary for Pharmacyclics (NASDAQ:PCYC)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/14/2014NomuraLower Price Target$177.00 -> $174.00ViewTweet This Rating  Share This Rating on StockTwits
7/3/2014ZacksReiterated RatingNeutral -> Neutral$98.00ViewTweet This Rating  Share This Rating on StockTwits
6/30/2014Credit SuisseReiterated RatingOutperform$121.00ViewTweet This Rating  Share This Rating on StockTwits
5/27/2014RBC CapitalDowngradeOutperform -> Sector Perform$110.00 -> $95.00ViewTweet This Rating  Share This Rating on StockTwits
5/27/2014Morgan StanleyLower Price TargetEqual Weight$100.00 -> $95.00ViewTweet This Rating  Share This Rating on StockTwits
5/2/2014Piper JaffrayDowngradeOverweight -> NeutralViewTweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralViewTweet This Rating  Share This Rating on StockTwits
2/24/2014Roth CapitalBoost Price Target$183.00ViewTweet This Rating  Share This Rating on StockTwits
2/21/2014Deutsche BankBoost Price TargetBuy$170.00 -> $180.00ViewTweet This Rating  Share This Rating on StockTwits
2/21/2014JMP SecuritiesSet Price Target$163.00 -> $191.00ViewTweet This Rating  Share This Rating on StockTwits
2/21/2014Robert W. BairdBoost Price Target$163.00 -> $173.00ViewTweet This Rating  Share This Rating on StockTwits
12/18/2013WallachBeth CapitalInitiated CoverageHold$108.00ViewTweet This Rating  Share This Rating on StockTwits
11/14/2013WedbushReiterated RatingOutperform$165.00ViewTweet This Rating  Share This Rating on StockTwits
10/30/2013Goldman SachsReiterated RatingBuy$170.00ViewTweet This Rating  Share This Rating on StockTwits
10/4/2013Wells Fargo & Co.Initiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
9/26/2013JPMorgan Chase & Co.Initiated CoverageOverweight -> Overweight$142.00 -> $170.00ViewTweet This Rating  Share This Rating on StockTwits
9/23/2013Lazard Capital MarketsReiterated RatingBuy$141.00ViewTweet This Rating  Share This Rating on StockTwits
9/23/2013William BlairInitiated CoverageOutperform$143.00ViewTweet This Rating  Share This Rating on StockTwits
4/4/2013TheStreetDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
2/19/2013Leerink SwannDowngradeOutperform -> Market Perform$80.00 -> $97.00ViewTweet This Rating  Share This Rating on StockTwits
1/14/2013Lazard LtdDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
12/7/2012Dawson JamesInitiated CoverageOutperform$101.00ViewTweet This Rating  Share This Rating on StockTwits
8/24/2012Stifel NicolausInitiated CoverageHoldViewTweet This Rating  Share This Rating on StockTwits
8/20/2012Rodman & RenshawBoost Price TargetOutperform$75.00ViewTweet This Rating  Share This Rating on StockTwits
8/2/2012Needham & Company LLCDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2012 forward)